###begin article-title 0
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 25 28 25 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
CRD-BP shields c-myc and MDR-1 RNA from endonucleolytic attack by a mammalian endoribonuclease
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 129 132 129 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 178 181 178 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 308 316 308 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 471 474 471 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 548 551 548 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 621 624 621 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 647 650 647 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 675 676 675 676 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 935 938 935 938 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1141 1144 1141 1144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1276 1279 1276 1279 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1286 1289 1286 1289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
The c-myc mRNA coding region determinant-binding protein (CRD-BP) has high affinity for the coding region determinant (CRD) of c-myc mRNA. Such affinity is believed to protect c-myc CRD from endonucleolytic attack. We have recently purified a mammalian endoribonuclease which can cleave within the c-myc CRD in vitro. The availability of this purified endonuclease has made it possible to directly test the interaction between CRD-BP and the endonuclease in regulating c-myc CRD RNA cleavage. In this study, we have identified the coding region of MDR-1 RNA as a new target for CRD-BP. CRD-BP has the same affinity for c-myc CRD nts 1705-1886 and MDR-1 RNA nts 746-962 with Kd of 500 nM. The concentration-dependent affinity of CRD-BP to these transcripts correlated with the concentration-dependent blocking of endonuclease-mediated cleavage by CRD-BP. In contrast, three other recombinant proteins tested which had no affinity for c-myc CRD did not block endonuclease-mediated cleavage. Finally, we have identified RNA sequences required for CRD-BP binding. These results provide the first direct evidence that CRD-BP can indeed protect c-myc CRD cleavage initiated by an endoribonuclease, and the framework for further investigation into the interactions between CRD-BP, c-myc mRNA, MDR-1 mRNA and the endoribonuclease in cells.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 171 172 171 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 281 282 269 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 438 439 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 507 510 495 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 273 279 <span type="species:ncbi:9606">humans</span>
###xml 308 313 <span type="species:ncbi:9606">human</span>
The c-Myc protein is an important transcription factor. It influences cell proliferation, differentiation and apoptosis via the activation of a multitude of target genes (1). It has been estimated that c-Myc can influence the expression of approximately10% of all genes in humans (1). c-Myc is implicated in human cancers, and overexpression of c-Myc at the protein and/or mRNA levels has been observed in virtually all types of cancers (2). These observations highlight the significance of understanding c-myc gene regulation.
###end p 4
###begin p 5
###xml 88 91 88 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3 B4 B5">3&#8211;5</xref>
###xml 143 150 143 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 531 532 531 532 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 607 610 607 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 671 674 671 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 700 701 700 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 702 706 702 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8 B9 B10 B11">8&#8211;11</xref>
c-Myc expression is regulated at multiple levels including the level of mRNA stability (3-5). By using a cell-free mRNA decay assay as well as in vivo analysis, it has been shown that c-myc mRNA can be degraded by two different pathways. One pathway involves rapid removal of the poly(A) tail which is then followed by 3'-5' decay accomplished by 3'-5' exoribonuclease(s) (6,7). The second decay pathway involves endonucleolytic cleavage within the coding region of c-myc mRNA, a region termed the coding region determinant (CRD) (5). Several studies have subsequently confirmed that the coding region of c-myc mRNA, including the CRD, is involved in the regulation of c-myc mRNA stability in cells (3,8-11).
###end p 5
###begin p 6
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 224 225 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 322 325 322 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 361 364 361 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 371 372 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 425 426 425 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 466 469 466 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 700 703 700 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 818 826 818 826 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 836 839 836 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 863 865 863 865 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 910 913 910 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1050 1052 1050 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
A cell-free mRNA decay assay involving polysome extracts and a 180 nt RNA sense strand corresponding to the c-myc CRD was found to induce endonucleolytic cleavage within the c-myc CRD and destabilized the transcript 8-fold (5). The effect was highly specific because competitor RNA corresponding to other regions of the c-myc transcript failed to destabilize c-myc mRNA (5). Based on these observations, Ross and co-workers (5) postulated the following model: (i) c-myc mRNA is susceptible to attack by a polysome-associated endoribonuclease; (ii) a protein can interact with and protect the CRD from attack by an endoribonuclease; (iii) the addition of competitor CRD RNAs titrate the protein off c-myc mRNA, leaving the CRD unprotected and susceptible to endonuclease attack. A protein that binds with high affinity in vitro to the c-myc CRD has been purified (12) and cloned (13). This protein termed the c-myc mRNA coding region determinant-binding protein or CRD-BP, was later found to be identical to the IGF-II mRNA-binding protein 1 (IMP-1) (14).
###end p 6
###begin p 7
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 364 371 364 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">De novo</italic>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 477 479 477 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 532 534 532 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 709 711 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 804 806 792 794 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 639 644 <span type="species:ncbi:9606">human</span>
###xml 718 733 <span type="species:ncbi:10090">transgenic mice</span>
The following observations supported CRD-BP being an oncofetal protein. CRD-BP has been shown to be abundantly expressed in fetal tissues but not in adult tissues (15). CRD-BP-deficient mice exhibited dwarfism, impaired gut development and increased perinatal mortality (16), providing further support that CRD-BP plays a critical role in developmental processes. De novo expression studies on CRD-BP have shown it to be overexpressed in breast cancer (17), colorectal cancer (18), brain tumors (19) and non-small cell lung tumors (19). Further evidence to associate CRD-BP with breast cancer are the observations that approximately30% of human breast cancer cases exhibited amplification of the CRD-BP gene (20), and transgenic mice carrying targeted expression of the protein developed mammary tumors (21).
###end p 7
###begin p 8
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF</italic>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 319 320 319 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tau</italic>
###xml 362 364 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 526 528 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 619 621 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 813 815 804 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 912 915 903 906 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 992 993 983 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
To date, CRD-BP and its orthologs have been shown to bind to several RNAs, and depending on the RNA in question, multiple functions for these proteins have been proposed. CRD-BP binds to the 5'-untranslated region of IGF-II mRNA and influences its subcellular localization and translation (14,22). CRD-BP also binds to H19 RNA (23) and neuron-specific tau mRNA (24) to influence their localization in cells. The zipcode-binding protein binds to beta-actin mRNA and localizes it to the leading edge of fibroblast lamellipodia (25). The IMP binds to the 3'-untranslated region of CD44 mRNA and stabilizes the transcript (26). A recent study has identified CRD-BP as the protein that interacts with the coding region of betaTrCP1 mRNA and stabilizes the transcript in response to the beta-catenin signaling pathway (27). Finally, as indicated above, CRD-BP has been shown to bind to and is believed to shield the c-myc CRD from endonucleolytic attack thereby prolonging its cytosolic half-life (5).
###end p 8
###begin p 9
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 163 166 163 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 180 182 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 423 425 423 425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 503 506 503 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 632 635 632 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 642 644 642 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 718 721 718 721 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 735 737 735 737 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 890 893 890 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 999 1002 999 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1028 1036 1028 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 1041 1048 1041 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 537 552 <span type="species:ncbi:10090">transgenic mice</span>
Three observations support the CRD-BP-c-myc CRD shielding hypothesis. First, overexpression of CRD-BP in colorectal cancer correlates with a modest elevation of c-myc mRNA levels (18). Second, decreased expression of c-myc mRNA subsequent to knockdown of CRD-BP was observed in MCF-7 (28) and colorectal cells (27). Finally, addition of sense RNA corresponding to the CRD resulted in enhanced decay of c-myc mRNA in cells (29). However, the following two recent observations do not support the CRD-BP-c-myc CRD shielding hypothesis: (i) transgenic mice over-expressing CRD-BP in mammary tissues did not exhibit elevated levels of c-myc mRNA (21); and (ii) targeted knockdown of CRD-BP in K562 cells had no effect on c-myc mRNA levels (30). Such unexpected results or discrepancies may in part be due to the role of the third party molecule, namely an endoribonuclease that can cleave the c-myc CRD. The availability of an identified endoribonuclease should permit systematic testing of the CRD-BP-c-myc CRD shielding hypothesis in vitro and in vivo, and may help clarify some of the contradictory reports.
###end p 9
###begin p 10
###xml 114 117 114 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 440 446 437 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 453 455 450 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 583 586 580 583 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 686 689 683 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 702 705 699 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 717 718 714 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 718 719 715 716 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 831 834 816 819 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 843 846 828 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 60 63 <span type="species:ncbi:10116">rat</span>
We have recently purified a mammalian endoribonuclease from rat liver based on its ability to cleave within the c-myc CRD (31). Several biochemical properties distinguished the enzyme from previously described vertebrate endonucleases and supported it being a novel mammalian endoribonuclease (31). The enzyme preferentially cleaves between the dinucleotides UA, CA and UG, and it is capable of cleaving other RNAs including MDR-1 and beta-globin RNAs (31). With the availability of purified mammalian endoribonuclease and recombinant CRD-BP, we sought to directly test the CRD-BP-c-myc CRD-shielding hypothesis. In this study, we show that CRD-BP is able to dose-dependently bind to c-myc CRD RNA and MDR-1 RNA with Kd of approximately500 nM. This interaction correlates with its ability to dose-dependently inhibit cleavage of c-myc CRD and MDR-1 RNA by the mammalian endoribonuclease.
###end p 10
###begin title 11
MATERIALS AND METHODS
###end title 11
###begin title 12
Expression and purification of recombinant CRD-BP, Rpp20, Rpp21, Rpp25 and Rpp40
###end title 12
###begin p 13
###xml 170 172 170 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 390 395 390 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32 B33 B34">32&#8211;34</xref>
###xml 405 406 405 406 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 442 458 442 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Escherichia coli</italic>
###xml 931 933 931 933 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 44 49 <span type="species:ncbi:10090">mouse</span>
###xml 442 463 <span type="species:ncbi:511693">Escherichia coli BL21</span>
The plasmid pET28b(+)-CRD-BP which contains mouse CRD-BP cDNA was a generous gift from Dr Jeffrey Ross, University of Wisconsin and was prepared as previously described (13). Plasmids pHTT7k-p20, pHTT7k-p21, pHTT7k-p25 and pHTT7k-p40 which contain the Rpp20, Rpp21, Rpp25 and Rpp40 cDNAs were generous gifts from Dr Sidney Altman, Yale University and were prepared as previously described (32-34). All His6-tagged proteins were purified from Escherichia coli BL21(DE3) using the QIAexpress Ni-NTA metal affinity spin kit (QIAGEN) under denaturing conditions. Proteins eluted from the column at either pH 5.4 or 4.5 were subjected to a series of dialysis steps (3 h at each step) pH 5/6 M urea, pH 5.5/4 M urea, pH 6/2 M urea, pH 6.7/1M urea and pH 7.4/0 M urea in a buffer containing 200 mM KCl, 1 mM EDTA, 10% (v/v) glycerol, 1 mM reduced glutathione, 0.1 mM oxidized glutathione, 0.01% (v/v) Triton X-100, 20 mM triethanolamine (13) and EDTA-free protease inhibitor tablets (Roche). Following dialysis, samples were spun at 13,200 rpm for 30 min to remove any precipitated proteins. The purified protein solutions were then quantified and analyzed for purity using Coomasie blue-stained 12% SDS-PAGE.
###end p 13
###begin title 14
Purification of the mammalian endoribonuclease
###end title 14
###begin p 15
###xml 94 96 94 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Purification of the mammalian endoribonuclease from rat livers has been previously described (31). One unit of the purified enzyme from the last step of column chromatography, the heparin-sepharose column, was used in all experiments described in this study.
###end p 15
###begin title 16
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro transcription and labeling of 5' ends of RNA
###end title 16
###begin p 17
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 62 64 62 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 224 230 221 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 289 291 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B35">35</xref>
###xml 398 401 388 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 457 460 447 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 486 489 476 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Apa</italic>
###xml 581 583 571 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 615 623 604 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in-vitro</italic>
###xml 1011 1013 986 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1211 1213 1180 1182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 392 397 <span type="species:ncbi:9606">human</span>
###xml 684 688 <span type="species:ncbi:9913">calf</span>
To synthesize c-myc CRD RNA, plasmids pUC19-CRDmyc-1705-1792 (31) and pUC19-CRDmyc-1705-1886 were linearized with EcoRI and transcribed with SP6 RNA polymerase using SP6 Megascript kits (Ambion, TX, USA). To make human beta-globin RNA corresponding to nts 1-145, the plasmid SPkappabetac (35) was linearized with FokI and transcribed with SP6 RNA polymerase using SP6 Megascript kit. To make human MDR-1 RNA corresponding to nts 746-962, the plasmid pGEM7Z-MDR-1-V2 was linearized with ApaLI and transcribed with T7 RNA polymerase using T7 Megascript kit (Ambion, TX, USA). For 5'-32P-end labeling of RNA, 5 mug of in-vitro transcribed RNA was first dephosphorylated with 10 units of calf alkaline phosphatase (GE Healthcare) for 30 min at 37degreesC in a 100-mul reaction according to the manufacturer's instructions. Dephosphorylated RNA was purified by phenol/chloroform extraction and ethanol precipitation. About 2.5 mug of dephosphorylated RNA was incubated in a 25-mul reaction with 30-50 muCi of [gamma-32P] ATP at 37degreesC for 1 h with 40-50 units of T4 polynucleotide kinase (New England Biolabs). The entire sample was then run on a 6% polyacrylamide/7M urea gel and the band containing 5'-labeled 32P-RNA was excised and eluted with elution buffer (0.5 M ammonium acetate, 1 mM EDTA, 0.2% SDS) at 37degreesC for 6 h. The purified radiolabeled RNA was then concentrated by ammonium acetate/isopropanol precipitation. Specific activity of the RNA was determined by scintillation counting.
###end p 17
###begin title 18
Electrophoretic mobility shift assays
###end title 18
###begin p 19
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 310 312 310 312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 135 141 <span type="species:ncbi:9913">bovine</span>
###xml 167 172 <span type="species:ncbi:4932">yeast</span>
Electrophoretic mobility shift assay (EMSA) binding buffers (5 mM Tris-Cl pH 7.4, 2.5 mM EDTA pH 8.0, 2 mM DTT, 5% glycerol, 0.1 mg/ml bovine serum albumin, 0.5 mg/ml yeast tRNA, 5 units RNasin) (13) were prepared on ice prior to each experiment. In order to facilitate RNA denaturation and renaturation, the [32P] RNA sample was heated to 50degreesC for 5 min and cooled to room temperature before being added to the EMSA-binding buffer. EMSA-binding buffer containing radiolabeled RNA was then incubated with purified recombinant protein in a 20-mul reaction volume at 30degreesC for 10 min and transferred to ice for 5 min. The reaction was again incubated at 30degreesC for 10 min and transferred to ice for an additional 5 min. Heparin (Sigma) was then added to a final concentration of 5 mg/ml and the reaction was incubated on ice for a final 5-min period. A total of 2 mul EMSA loading dye (250 mM Tris-Cl pH 7.4, 0.2% bromophenol blue, 0.2% xylene cyanol, 40% sucrose) was added to each reaction and 10 mul of the EMSA reaction was loaded onto an 8% native polyacrylamide gel and resolved at 25 mA for 90 min. Following electrophoresis, the gel was dried and subjected to autoradiography using the Cyclone PhosphorImager and Optiquant Software.
###end p 19
###begin p 20
###xml 107 108 107 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 108 109 108 109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 130 133 130 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 142 145 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 202 203 202 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 203 204 203 204 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">L</italic>
###xml 277 278 277 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
All EMSA saturation-binding experiments were carried out as described above and the dissociation constant (Kd) for CRD-BP against MDR-1 and c-myc CRD was determined by fits to the Hill equation:  where Kd is the dissociation constant and [L] is the concentration of CRD-BP and n is the Hill coefficient. All saturation-binding data was analyzed by densitometry of the autoradiograph using the Cyclone Storage Phosphor-System and Optiquant software. For each reaction the total activity in each lane was determined; this involved summing the total activity in bound complexes with the total activity present in the unbound fraction. It should be noted that in lanes in which both Complex I and Complex II were present, their total activity was added together and therefore represented the total bound fraction. This analysis allowed for the calculation of the percentage of RNA bound to the protein. The percentage of bound RNA and the protein concentration (nM) were inserted into the Hill equation and the results were expressed graphically.
###end p 20
###begin p 21
###xml 33 35 33 35 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 93 101 93 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 370 373 370 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 384 390 381 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 545 547 536 538 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 552 555 543 546 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 772 774 763 765 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 779 782 770 773 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
For EMSA competition assays, 5'-[32P] radiolabeled c-myc CRD RNA nts 1705-1886 and unlabeled in vitro transcribed competitor RNA were prepared as described above. EMSA-binding buffers and EMSA reaction mixtures were prepared and 350 nM of CRD-BP was added to the reactions containing one of the following unlabeled competitors: c-myc-CRD-1705-1885, c-myc-CRD 1705-1792, MDR-1 or beta-globin RNA. EMSA competition assays involved the pre-incubation between competitor RNA and CRD-BP for 10 min at 30degreesC. Following the pre-incubation, 40 nM [32P] c-myc CRD RNA was added to the reaction. This was followed by the standard EMSA protocol as described above. The concentrations of unlabeled competitor RNA employed were 1-, 2-, 5-, 10- and 50-fold greater than the 40 nM [32P] c-myc-CRD RNA used.
###end p 21
###begin title 22
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
In vitro endonuclease shielding assay
###end title 22
###begin p 23
###xml 70 72 70 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 112 115 112 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 126 132 123 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
The first step of this assay involved the binding between one of the [32P] RNA constructs (c-myc CRD-1705-1886, MDR-1 or beta-globin) and one of the purified recombinant proteins (CRD-BP, Rpp20, Rpp21, Rpp25 or Rpp40). Binding was facilitated using the standard EMSA protocol. Immediately following the final EMSA step, one unit of the heparin-sepharose purified mammalian endoribonuclease was added to the binding reaction, mixed and incubated at 37degreesC for 3 min. As a positive control, the dialyzed mammalian endoribonuclease was added to the EMSA buffer in the absence of recombinant protein and incubated at 37degreesC for 3 min. All reactions were terminated by heating at 100degreesC for 3 min followed by the addition of 1 microl phenol and 3 microl formamide loading dye (80% formamide, 0.05 mg/ml bromophenol blue, 0.05 mg/ml xylene cyanol, 0.01 M EDTA pH 8.0). Aliquots containing approximately30 000 c.p.m. were loaded onto 8% denaturing polyacrylamide gel and resolved at 30 mA until the bromophenol blue reached the bottom of the gel plate. Gels were fixed in 10% acetic acid, 10% methanol for 15 min and subjected to autoradiography. In some experiments, higher amounts (three units) of the purified endoribonuclease were used. In such cases, similar blocking effects of CRD-BP on endonuclease-mediated cleavage were observed.
###end p 23
###begin p 24
###xml 61 64 61 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 223 225 223 225 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 230 233 230 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 298 299 298 299 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 302 303 302 303 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 305 306 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 625 627 604 606 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 632 635 611 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 332 337 <span type="species:ncbi:4932">yeast</span>
RNase T1 digestion and alkaline hydrolysis of radiolabeled c-myc CRD RNA were performed to generate sequencing ladders for cleavage site identification purposes. Alkaline ladders were generated by combining 100 000 c.p.m. [32P] c-myc CRD-1705-1886 RNA and 1x alkaline hydrolysis buffer (50 mM NaHCO3/Na2CO3 pH 9.2, 1 mM EDTA, 3 mug yeast tRNA) in a total reaction volume not exceeding 15 microl. The reaction was incubated at 95degreesC for 10 min, transferred to ice and combined with 20 microl of formamide loading dye and stored at -20degreesC until required. RNase T1 digests were generated by incubating 100 000 c.p.m. [32P] c-myc CRD-1705-1886 RNA in EMSA-binding buffer with 1 unit of RNase T1 (Ambion). The RNA/EMSA binding buffer mixture was heated to 55degreesC for 5 min and cooled to room temperature prior to the addition of RNase T1. The T1 cleavage reaction was incubated at room temperature for 10 min and was terminated by phenol/chloroform extraction. The RNA was extracted using ammonium acetate/isopropanol precipitation and was resuspended in 15 microl of formamide loading dye.
###end p 24
###begin title 25
Mapping of CRD-BP-binding sites using hydroxyl radical foot-printing
###end title 25
###begin p 26
###xml 34 36 34 36 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 84 87 84 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 132 135 132 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 400 401 384 385 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 402 403 386 387 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 406 407 390 391 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 408 409 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 437 438 421 422 <sc xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">l</sc>
###xml 473 474 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 475 476 459 460 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The Fe(II)/EDTA cleavage complex (36) was used to map the CRD-BP-binding sites on c-myc CRD-1705-1886. Initially, binding between c-myc CRD (approximately45 nM; 100 000 c.p.m./reaction) and CRD-BP (1500 nM) was facilitated using the standard EMSA buffer and reaction conditions as described above. Immediately following the binding reaction, 6 microl of Fe(II)/EDTA cleavage reagent (0.4 mM Fe(II)(NH4)2(SO4)2, 0.8 mM EDTA pH 8.0, 20 mM l-ascorbic acid sodium salt, 0.35% H2O2) was added to the 20 microl binding reaction. The cleavage reaction was incubated at room temperature for 10 min and was terminated by the addition of 5 microl 0.1 M Thiourea (Sigma). The RNA was extracted by ammonium acetate/isopropanol precipitation and the pellet was resuspended in 15 microl formamide loading dye. About 5 microl of the reaction was run on an 8% denaturing polyacrylamide-sequencing gel.
###end p 26
###begin title 27
RESULTS
###end title 27
###begin title 28
###xml 24 25 24 25 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
Purified recombinant His6-tagged CRD-BP binds to the full-length c-myc CRD RNA nts 1705-1886 and MDR-1 RNA nts 746-962
###end title 28
###begin p 29
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 134 135 134 135 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 275 276 275 276 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 459 467 447 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 567 569 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 591 592 579 580 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 703 711 679 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 891 896 867 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32 B33 B34">32&#8211;34</xref>
###xml 1313 1321 1289 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 246 251 <span type="species:ncbi:10090">mouse</span>
###xml 553 558 <span type="species:ncbi:10090">mouse</span>
###xml 876 881 <span type="species:ncbi:9606">human</span>
In an effort towards testing the CRD-BP-c-myc CRD shielding hypothesis, it was imperative to demonstrate that purified recombinant His6-tagged CRD-BP could bind avidly to the CRD. The plasmid pET28b(+)-CRD-BP was used to generate the recombinant mouse CRD-BP containing a His6-tag at the C-terminus of the protein. CRD-BP fractions eluted from the Ni-NTA column contained an enriched band at approximately68 kDa when visualized by SDS-PAGE, (refer to lane 3, Figure 1) which is consistent with the predicted and reported molecular weight of recombinant mouse CRD-BP (13). The recombinant His6-tagged CRD-BP of approximately95% purity was consistently obtained and an example of this is shown in lane 3, Figure 1. Additional recombinant proteins, Rpp20, Rpp21, Rpp25 and Rpp40, were used as controls in this investigation. Rpp20, Rpp21, Rpp25 and Rpp40 are protein subunits of human RNase P (32-34) and were chosen on the basis of their ability or inability to bind to nucleic acids. The criteria used to determine if these recombinant proteins possessed this binding potential was based on the presence of putative nucleic-acid-binding domains in their sequence and known RNA-protein interactions. Purity of the recombinant proteins was assessed by visualization using Coomasie blue-stained SDS-PAGE. As shown in Figure 1, the purity of all the recombinant proteins was greater than 95% and their observed molecular weights were consistent with their predicted molecular weights (lanes 2, 4, 5, 7). 
###end p 29
###begin p 30
###xml 116 119 116 119 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 196 199 196 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 205 207 205 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 321 329 321 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 516 519 516 519 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 525 527 525 527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 617 620 617 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 626 628 626 628 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 686 689 686 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 773 775 773 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 776 778 776 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 856 857 856 857 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">H</italic>
###xml 864 865 864 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</italic>
###xml 875 882 875 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E. coli</italic>
###xml 887 890 887 890 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tyr</sup>
###xml 892 894 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 1144 1147 1144 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1297 1300 1297 1300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1424 1426 1424 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 1427 1429 1427 1429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 875 882 <span type="species:ncbi:110766|species:ncbi:562">E. coli</span>
###xml 1155 1160 <span type="species:ncbi:4932">yeast</span>
EMSA was performed to determine whether the purified and dialyzed recombinant proteins were capable of binding to c-myc CRD RNA nts 1705-1886. About 500 nM recombinant CRD-BP was incubated with c-myc CRD [32P]RNA and RNA-protein complexes were visualized following non-denaturing gel electrophoresis. As shown in lane 2, Figure 2, two clear bound complexes were observed. In contrast, no bound complexes were observed when 500-750 nM Rpp20 (lanes 3-5), Rpp21 (lanes 6-8) or Rpp40 (lanes 12-14) were incubated with c-myc CRD [32P]RNA. Three low-activity binding complexes were observed when Rpp25 was incubated with c-myc CRD [32P]RNA (lanes 9-11). The ability of Rpp25 to bind to the c-myc CRD was not surprising given the fact that it possesses an Alba RNA-binding motif (37,38) and it is known to bind to several RNA targets including a 71-nt segment of H1 RNA, M1 RNA and E. coli tRNAtyr (34). It should be noted that the intensity of the Rpp25-binding complexes is significantly less than CRD-BP-binding complexes at the same concentration. Further study would be required to determine if Rpp25 has in fact lower affinity than CRD-BP for c-myc CRD or yeast tRNA present in the EMSA reaction actually competed with Rpp25 for binding to the transcript. The inability of Rpp40 to bind with the c-myc CRD was supported by the previous suggestions that this protein in isolation does not play a role in nucleic acid binding (37,38). 
###end p 30
###begin p 31
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 58 60 58 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 250 256 247 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 325 327 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 332 335 329 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 354 362 351 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 376 384 373 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 420 426 414 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 461 464 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 544 552 538 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 599 605 590 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 628 637 619 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona fide</italic>
###xml 652 660 643 651 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 671 677 659 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 757 759 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 760 762 748 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
To further determine if the recombinant CRD-BP-c-myc CRD [32P] RNA nts 1705-1886 association was specific, we chalenged the interaction with unlabeled competitor RNA. Our EMSA competition assays revealed that up to 50X molar excess of unlabeled beta-globin competitor RNA was unable to dilute the binding between CRD-BP and [32P] c-myc CRD (lanes 15-18, Figure 3A; lanes 7-8, Figure 3B). The inability of unlabeled beta-globin competitor to dilute the CRD-BP-c-myc CRD interaction in conjunction with the saturation-binding experiment shown in Figure 4C support the observation that the 145-nt beta-globin RNA fragment is not a bona fide CRD-BP target in vitro. The beta-globin results from this investigation are also supported by the two earlier reports (12,13). 
###end p 31
###begin p 32
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 72 80 72 80 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 108 111 108 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 166 168 166 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 173 176 173 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 221 229 221 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 340 348 340 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 383 391 383 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 457 460 457 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 520 528 520 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 562 570 562 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 601 604 601 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 738 746 738 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 791 793 791 793 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 798 801 798 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 868 876 868 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 939 942 939 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1033 1036 1033 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1056 1058 1056 1058 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 1114 1117 1114 1117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Similar to unlabeled c-myc CRD nts 1705-1886 (compare lane 3 to lane 2, Figure 3A), at 1x molar excess, the MDR-1 RNA nts 746-962 was capable of diluting the CRD-BP-[32P] c-myc CRD interaction (compare lane 11 to lane 2, Figure 3A) and at 5x, 10x and 50x molar excess it diluted the interaction completely (compare lanes 13-14 with lane 2, Figure 3A; compare lanes 9-10 with lane 2, Figure 3B). Similar results were observed when the unlabeled competitor c-myc CRD-1705-1886 RNA was used (compare lanes 5-6 with lane 2, Figure 3A; compare lanes 3-4 with lane 2, Figure 3B). The unlabeled competitor c-myc CRD nts 1705-1792 was also observed to dilute the interaction when a minimum of 2x molar excess was added (compare lane 8 to lane 2, Figure 3A) and even at 50x molar excess, the CRD-BP-[32P] c-myc CRD interaction was still visible (compare lanes 5-6 with lane 2, Figure 3B). This result is consistent with previous observation that c-myc CRD nts 1705-1792 has indeed reduced affinity for CRD-BP as compared to the full-length c-myc CRD nts 1705-1886 (13). It is possible that the secondary structure of the c-myc CRD-1705-1886 contains the full complement of recognition and binding elements that facilitate high-affinity-binding interactions with CRD-BP.
###end p 32
###begin title 33
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 58 61 58 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
Characterizing the binding of CRD-BP to c-myc CRD RNA and MDR1 RNA
###end title 33
###begin p 34
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 51 53 51 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 54 56 54 56 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 214 217 214 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 617 620 617 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 622 624 622 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 661 669 661 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1037 1045 1037 1045 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1250 1258 1250 1258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1300 1308 1300 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1410 1418 1410 1418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1421 1422 1421 1422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 1422 1423 1422 1423 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
Although CRD-BP is known to bind to the c-myc CRD (12,13), the binding characteristics between the two components has not been previously determined. With the availability of purified recombinant CRD-BP as well as MDR-1 RNA, we decided to further characterize and compare the nature of the binding interactions. Saturation-binding experiments were carried out using the standard EMSA conditions and employed a wide range of CRD-BP concentrations. The saturation-binding experiments were conducted three times, using three different purified CRD-BP preparations. A representative result for the binding of CRD-BP to c-myc [32P] CRD RNA nts 1705-1886 is shown in Figure 4A. It was determined experimentally that the minimum concentration of CRD-BP required to generate Complex I (binding of one molecule of CRD-BP, see below for discussion) was about 15 nM (data not shown). At concentrations above 100 nM, the slower migrating Complex II (binding of two molecules of CRD-BP, see below for discussion) was frequently observed (lanes 3-20, Figure 4A). In many instances, at higher concentrations of CRD-BP (e.g. 500-750 nM), Complex I was absent and it would appear that the bound RNA shifted exclusively to Complex II (compare lanes 8-20 to lanes 2-7, Figure 4A). When the saturation-binding data from Figure 4A was fit to the Hill equation and expressed graphically, a sigmoidal curve was generated as shown in Figure 4B (Kd of 500 nM). It is important to point out that the concentration of CRD-BP at which formation of Complexes I and II would take place was highly dependent upon the age of the dialyzed protein and the number of freeze-thaw cycles subjected to the protein. However, the actual dissociation constant may be lower than 500 nM because it cannot be assumed that 100% of the CRD-BP molecules were present in a conformation suitable for binding.
###end p 34
###begin p 35
###xml 189 191 189 191 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 199 205 196 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 286 294 283 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 340 342 337 339 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 345 348 342 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 435 438 432 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 470 471 467 468 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 471 472 468 469 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 483 491 480 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 679 687 676 684 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 787 790 784 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 796 804 793 801 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 846 849 843 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 857 865 854 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 970 973 967 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1006 1009 1003 1006 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 1176 1179 1173 1176 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF</italic>
###xml 1188 1190 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1309 1312 1306 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF</italic>
###xml 1328 1330 1325 1327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1435 1438 1432 1435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF</italic>
###xml 1447 1449 1444 1446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1587 1590 1584 1587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1640 1641 1637 1638 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 1740 1742 1737 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
Keeping in mind the limitation of the EMSA, we also performed saturation-binding experiments to determine if CRD-BP could bind with other radiolabeled RNA substrates. When challenged with [32P] beta-globin RNA, CRD-BP up to 3070 nM was unable to form an observable RNA-protein complex (Figure 4C). However, when CRD-BP was challenged with [32P] MDR-1, two RNA-protein complexes that exhibited a similar profile to that of the CRD-BP-c-myc CRD interaction were observed; Kd = 500 nM (Figure 5). The analysis of the combined binding data from three separate experiments revealed a level of cooperativity was present between the formation of the first and second binding complexes (Figure 5B). The cooperativity observed is also reflected in the Hill coefficient, which for CRD-BP versus c-myc CRD (Figure 4B) was 2.06, and 2.6 when challenged with MDR-1 RNA (Figure 5B). The Hill coefficients in both cases suggest that two molecules of CRD-BP bind with one molecule of c-myc CRD RNA or with one molecule of MDR-1 RNA at identical or non-identical sites. Evidence to support a two RNA-binding site model is provided by the kinetic analysis of the interactions between IMP-1 and IGF-II RNA (39). In this study, IMP-1 was shown to bind through a cooperative, sequential mechanism via two binding sites within the IGF-II transcript (39). Interestingly, dissociation constant of about 2 nM was reported for the interaction between IMP-1 and IGF-II RNA (39). The significantly higher dissociation constant determined in this study could reflect the inefficiency of renaturation of CRD-BP and c-myc CRD RNA as discussed above, or/and the use of His6-tagged CRD-BP since it has been previously reported that tagged-IMP-1 exhibited poor RNA binding (14). 
###end p 35
###begin title 36
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
CRD-BP protects the c-myc CRD and MDR-1 RNA from cleavage by the mammalian endoribonuclease
###end title 36
###begin p 37
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 250 252 250 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
Having established that recombinant CRD-BP can bind c-myc CRD and MDR-1 RNA, we then sought to determine if the binding of CRD-BP to RNA could directly protect these transcripts from degradation by an endoribonuclease recently discovered in our lab (31).
###end p 37
###begin p 38
###xml 17 20 17 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 158 166 158 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 557 565 557 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 771 774 771 774 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 890 893 890 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 924 932 924 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 1054 1062 1054 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
5'-End labeled c-myc CRD nts 1705-1886 was incubated with one unit of the purified endonuclease in the presence or absence of recombinant CRD-BP. As shown in Figure 6A, the typical ten distinct cleavage sites at nts 1742, 1747, 1751, 1757, 1768, 1771, 1773, 1775, 1845 and 1855 were generated upon incubation with the purified endonuclease (lanes 3, 8 and 13) (31). For ease in quantification and categorization, we have named the separate cleavage sites as Region I (1845, 1855), Region II (1768, 1771, 1773, 1775) and Region III (1742, 1747, 1751, 1757) (Figure 6). Incubation of the transcript with recombinant CRD-BP at 500 nM (lane 2), 750 nM (lane 7) and 1500 nM (lane 12) alone had no effect, indicating that CRD-BP lacks RNase activity. It was anticipated that c-myc cleavage would be reduced using CRD-BP concentrations equal to the measured dissociation constant because 50% of c-myc CRD would be bound at 500 nM (Figure 4A and B). This prediction was confirmed by the reduction in cleavage fragments observed in all three regions indicated in Figure 6A (compare lanes 4-5 with lane 3). At 500 nM, CRD-BP was responsible for a 43% reduction in Region I, a 72% reduction in Region II and a 77% reduction in Region III. 
###end p 38
###begin p 39
###xml 173 176 161 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 216 224 204 212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 258 266 246 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
###xml 416 424 404 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
It was predicted that cleavage reductions would increase at concentrations above the measured dissociation constant because at 750 and 1500 nM, approximately75 and 90% of c-myc CRD were bound by CRD-BP respectively (Figure 4A and B). At 750 nM, (lanes 9-10, Figure 6A) CRD-BP was responsible for a 45% reduction in Region I, a 75% reduction in Region II and a 80% reduction in Region III. As shown in lanes 14-15 in Figure 6A, at 1500 nM, CRD-BP was responsible for the 95% cleavage reductions observed in all three regions.
###end p 39
###begin p 40
###xml 93 96 93 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 194 202 194 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 205 213 205 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F6">Figure 6</xref>
To determine if the blocking effect was due to specific binding interactions, we incubated c-myc CRD RNA with Rpp20, Rpp21 and Rpp40 which had been shown to have no affinity for the transcript (Figure 2). Figure 6B shows that at 1500 nM, Rpp20, Rpp21 and Rpp40 were unable to block endonucleolytic cleavage of CRD RNA by the native mammalian endoribonuclease (compare lanes 4, 6 and 8 to lane 2).
###end p 40
###begin p 41
###xml 71 74 71 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 82 90 82 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 166 169 166 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 177 179 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 257 260 257 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 426 434 426 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 517 525 517 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
###xml 603 606 603 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 720 726 717 723 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 802 808 796 802 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 814 822 808 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 899 907 893 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F7">Figure 7</xref>
CRD-BP was shown to bind with considerable affinity and specificity to MDR-1 RNA (Figure 5) and we have previously shown that the endonuclease is capable of cleaving MDR-1 RNA (31). It was therefore anticipated that CRD-BP would also be capable of blocking MDR-1 cleavage by the mammalian endoribonuclease. As predicted, CRD-BP was observed to shield MDR-1 RNA from endonucleolytic attack in a concentration-dependent manner (Figure 7A), and the most significant cleavage reductions were observed at 1500 nM (lane 3, Figure 7A). The consistent reduction observed in all regions suggests that the entire MDR-1 RNA was protected via CRD-BP interactions. We have also tested the ability of CRD-BP to block cleavage of beta-globin RNA by the endonuclease. As expected, CRD-BP that had no affinity for beta-globin RNA (Figure 4C) did not effectively block the endonuclease from cleaving this transcript (Figure 7B). 
###end p 41
###begin p 42
###xml 88 91 88 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 323 326 323 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 335 338 335 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Taken together, our overall results suggest that CRD-BP was capable of shielding both c-myc CRD and MDR-1 RNAs in a dose-dependent manner from the cleavage activities of a mammalian endoribonuclease via specific RNA-protein interactions. In addition, the results suggest that CRD-BP binds to a considerable portion of both MDR-1 and c-myc RNAs and at 1500 nM, both RNA transcripts appeared to be entirely protected.
###end p 42
###begin title 43
###xml 38 41 38 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Mapping the CRD-BP-binding sites on c-myc CRD RNA
###end title 43
###begin p 44
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 97 99 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 496 498 496 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
###xml 784 786 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
To map the CRD-BP-binding sites on c-myc CRD, we used the hydroxyl radical foot-printing method (36). The chemical cleavage reagent chosen was the Fe(II)/EDTA complex. The Fe(II)/EDTA complex is a negatively charged species and does not interact electrostatically with the RNA molecule thereby limiting its interference with RNA-protein interactions (36). The complex is known to generate hydroxyl radicals from the reduction of hydrogen peroxide in a reaction known as the Haber-Weiss reaction (36). The hydroxyl radical is thought to cleave the RNA backbone by attacking ribose moieties (36). Regions of the RNA backbone that are occluded by protein are cleaved with decreased efficiency by the radical and the result is a series of cleavage fragments exhibiting reduced intensity (36).
###end p 44
###begin p 45
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 35 38 35 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 136 138 136 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 143 146 143 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 403 405 403 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 410 413 410 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 567 570 567 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 664 672 664 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 1238 1246 1238 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 1399 1401 1399 1401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1546 1551 1546 1551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 1554 1556 1554 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1804 1812 1804 1812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 1901 1904 1901 1904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Figure 8A shows a typical CRD-BP-c-myc CRD foot-printing experiment. Lane 3 depicts the Fe(II)/EDTA cleavage profile characteristic of [32P] c-myc CRD-1705-1886 in the absence of CRD-BP. The alkaline hydrolysis ladder (lane 2) exhibited a uniform cleavage profile with the exception of two enriched fragments located between nts 1794 and 1842; which were also observed in lanes 4-9. RNase T1 digest of [32P] c-myc CRD-1705-1886 shown in lane 1 provided mapping for cleavage site identification. The cleavage pattern observed as a result of Fe(II)/EDTA-treatment of c-myc CRD was hallmarked by several enriched fragments which have been mapped and are indicated in Figure 8A. When compared to cleavage reactions containing 1500 nM CRD-BP (lanes 4-7), it is apparent that several regions of cleavage were significantly reduced. The cleavage fragments corresponding to nts 1741 and 1748 (lane 3) were reduced by 75%. An equivalent reduction was also observed at discrete fragments in the nucleotide region spanning 1765-1775 (compare lane 3 with lanes 4-7). At positions 1787 and 1791, a 50% reduction in cleavage intensity was observed and a 75% reduction was also observed at positions 1843, 1855 and 1864 (compare lane 3 with lanes 4-7). Figure 8B shows the identified CRD-BP-binding sites in comparison with the putative CRD-BP-binding sites previously determined using antisense oligonucleotides (29). Six of the binding sites (1765, 1767, 1771, 1773, 1775, 1787) identified in this study were in good agreement with those identified by Coulis et al. (29). Six identified CRD-BP-binding sites (1747, 1767, 1771, 1773, 1855) are within the direct cleavage sites of the mammalian endonuclease and five (1741, 1765, 1787, 1791, 1843) are within one to two nucleotides away from the enzyme cleavage sites (Figure 8B). Such observation is consistent with the notion that CRD-BP is capable of shielding c-myc CRD RNA from attack by the endonuclease. 
###end p 45
###begin title 46
DISCUSSION
###end title 46
###begin p 47
###xml 154 156 154 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 262 265 262 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 348 351 348 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 446 447 446 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 496 504 496 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 525 526 525 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 560 561 560 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 562 564 562 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 957 960 957 960 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 969 972 969 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 1088 1091 1088 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1100 1103 1100 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
CRD-BP belongs to the VICKZ family of RNA-binding proteins that influence various aspects of cellular physiology such as cell growth and differentiation (40). CRD-BP was initially discovered (5) and eventually purified (12) based on its ability to bind to the c-myc CRD. The working model for CRD-BP function is that it binds to and protects the c-myc CRD from endonucleolytic cleavage, resulting in enhanced transcript half-life and expression (5). This hypothesis is supported by evidence from in vitro mRNA decay studies (5,12) as well as studies in cells (3,28). Although this hypothesis has been proposed for a number of years, it has not been directly tested. That is CRD-BP has not been directly shown to block CRD cleavage by an endoribonuclease. This is in part due to the unavailability of a candidate endoribonuclease that can cleave within the c-myc CRD. In this study, we show that recombinant CRD-BP can dose-dependently inhibit cleavage of c-myc CRD and MDR-1 RNA by a mammalian endoribonuclease. This blocking effect correlates with CRD-BP's dose-dependent affinity for c-myc CRD and MDR-1 RNAs.
###end p 47
###begin p 48
###xml 169 172 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 231 239 231 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 288 290 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 295 298 295 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 353 355 353 355 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 359 362 359 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 449 457 449 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 503 509 500 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 538 540 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 544 547 541 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 623 626 620 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 667 670 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 725 733 722 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 846 848 843 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 850 853 847 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 861 869 858 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
Specificity of recombinant CRD-BP for the CRD was demonstrated in two ways. First, while three other recombinant proteins, Rpp20, Rpp21 and Rpp40, had no affinity for c-myc CRD, CRD-BP was shown to bind strongly to the transcript (Figure 2). Second, consistent with previous findings (12,13), c-myc CRD competitor RNAs were effective in competing with [32P]c-myc CRD in binding to CRD-BP, with nts 1705-1886 being more effective than nts 1705-1792 (Figure 3). On the contrary, at 50x molar excess, beta-globin RNA could not compete with [32P]c-myc CRD in binding to CRD-BP. Unexpectedly, we found that the coding region of MDR-1 RNA nts 746-962 was as effective as c-myc CRD nts 1705-1886 in competing for binding to CRD-BP (Figure 3). This result is consistent with the observed saturating-binding profile upon incubation of excess CRD-BP with [32P]MDR-1 RNA (Figure 5).
###end p 48
###begin p 49
###xml 4 5 4 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 5 6 5 6 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 24 27 24 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 397 400 397 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 416 419 416 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 861 862 861 862 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 862 863 862 863 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">d</sub>
###xml 1394 1397 1394 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IGF</italic>
###xml 1406 1408 1406 1408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 1421 1424 1421 1424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">VLE</italic>
###xml 1437 1439 1437 1439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
The Kd for the CRD-BP-c-myc-1705-1886 interaction was significantly lower than that of CRD-BP-c-myc-1705-1792 interaction. It is apparent that one of the proposed CRD-BP-binding sites (nts 1843-1864) is absent from the 1705-1792 CRD region, and may attributed to the differences in specificity and stability observed in the RNA-protein interactions. The binding profiles exhibited by the CRD-BP-c-myc CRD and CRD-BP-MDR-1 interactions were hallmarked by the presence of two binding complexes. These RNA-protein interactions are believed to occur via a sequential, cooperative binding mechanism. The formation of the faster migrating Complex I at low concentrations of CRD-BP, the emergence of the slower migrating Complex II at intermediate concentrations of CRD-BP and the predominance of Complex II at concentrations greater than (or) equal to the calculated Kd are suggestive of a sequential binding mechanism. It is possible that the formation of Complex I may represent an intermediate state in which one molecule of CRD-BP is bound to one RNA molecule. The emergence of Complex II suggests that a second molecule of CRD-BP engages in interactions with a Complex I species in a concentration-dependent manner. We propose that Complex II may function to increase the stability and specificity of the RNA-protein interaction. Such interactions have also been observed and proposed for IMP-1-IGF-II RNA (39) and Vg1RBP-VLE 3'-UTR RNA (41).
###end p 49
###begin p 50
###xml 67 70 67 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 248 251 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 600 608 600 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F8">Figure 8</xref>
###xml 836 838 836 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 974 977 974 977 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 983 985 983 985 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1175 1187 1175 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc in vitro</italic>
###xml 1322 1325 1322 1325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Our data demonstrated that the blocking of endonuclease-mediated c-myc CRD cleavage by CRD-BP is concentration dependent and this correlated with concentration-dependent binding of CRD-BP to the transcript. We propose that at 500 nM CRD-BP, most c-myc CRD RNA molecules are bound by only one molecule of CRD-BP. At 1500 nM CRD-BP, c-myc CRD RNA is likely to be bound by two molecules of CRD-BP as observed by the formation of Complex II. In this scenario, it is highly likely that the entire transcript is bound and protected by CRD-BP as evidenced by the hydroxyl radical foot-printing experiments (Figure 8). Our observations that CRD-BP binds to larger stretches of nucleotides rather than to specific positions is supported by evidence that members of the VICKZ family bind to larger elements rather than to individual nucleotides (40). Further evidence to support this came from a study using complementary oligonucleotides to map the CRD-BP-binding sites within the c-myc CRD (29). Our findings of the presence of CRD-BP-binding sites within the regions targeted by the mammalian endoribonuclease support the hypothesis that CRD-BP serves as a stabilizing factor for c-myc in vitro. The evidence provided in this study confirms that CRD-BP is in fact capable of blocking a mammalian endoribonuclease from cleaving c-myc CRD via specific interactions with RNA sequences.
###end p 50
###begin p 51
###xml 101 104 101 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 265 268 265 268 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 377 379 377 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 380 382 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 383 385 383 385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 386 388 386 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 452 455 452 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 925 928 925 928 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
To our knowledge, this is the first study to demonstrate the ability of CRD-BP to directly protect c-myc CRD cleavage by an endoribonuclease. This is a critical first step towards directly testing the interaction between CRD-BP and endoribonuclease in regulating c-myc CRD cleavage in cells. As indicated in the Introduction, four studies indirectly supported this hypothesis (18,27,28,29). However, two recent observations on the lack of changes in c-myc mRNA and protein levels upon changes in CRD-BP expression (21,30) are inconsistent with this working model. As previously suggested (21,30), the known multilevel regulation of c-myc gene expression could contribute to these observations. Alternatively, the absence of the responsible endoribonuclease may in part explain these unexpected findings. The latter hypothesis can be investigated upon availability of identified endoribonucleases that can cleave within the c-myc CRD.
###end p 51
###begin p 52
###xml 46 49 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 111 114 111 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 298 301 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 310 313 310 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 425 428 425 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 492 494 492 494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 615 618 615 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 623 626 623 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 775 778 775 778 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 787 790 787 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 798 800 798 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 250 255 <span type="species:ncbi:9606">human</span>
Our finding that CRD-BP has high affinity for MDR-1 RNA was totally unexpected and has important implications. MDR-1 is a plasma membrane drug-transporter protein and is associated with multidrug resistance phenotypes in cultured cells as well as in human cancers (42). Enhanced mRNA stability for MDR-1 and c-myc mRNA has been reported in liver cancer (43) and MDR-1 mRNA decay intermediates corresponding to nts 746-962 of MDR-1 have been detected in the normal liver but not liver cancer (44). Although CRD-BP expression has not been studied in liver cancer, results to date are consistent with the model that c-myc and MDR-1 mRNAs are short-lived in normal adult tissues (43) because CRD-BP is absent or present at low levels. However, in cancerous liver cells, enhanced MDR-1 and c-myc mRNAs (43) are observed because CRD-BP may be overexpressed.
###end p 52
###begin p 53
###xml 82 85 82 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 223 226 223 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
In conclusion, our data provides direct evidence that CRD-BP can indeed protect c-myc mRNA from cleavage by an endoribonuclease, and supports its proposed role in regulating mRNA stability in cells. We have also identified MDR-1 RNA as a new target for CRD-BP, and the transcript can also be protected from endonucleolytic cleavage by CRD-BP. These findings provided further support for the significant and global roles that CRD-BP play in regulating mRNA stability in cancer.
###end p 53
###begin title 54
ACKNOWLEDGEMENTS
###end title 54
###begin p 55
This work was supported by a grant from Natural Science & Engineering Research Council and Canadian Liver Foundation. C.H.L. is a Research Scientist of the National Cancer Institute of Canada supported with funds provided by the Canadian Cancer Society. We thank Andrea Gorrell for her assistance in the preparation of saturation-binding curves. Funding to pay the Open Access publication charge was provided by the NSERC Discovery Grant 227158.
###end p 55
###begin p 56
###xml 0 30 0 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflict of interest statement</italic>
Conflict of interest statement. None declared.
###end p 56
###begin title 57
REFERENCES
###end title 57
###begin article-title 58
Reconstructing MYC
###end article-title 58
###begin article-title 59
###xml 18 23 <span type="species:ncbi:9606">human</span>
MYC oncogenes and human neoplastic disease
###end article-title 59
###begin article-title 60
###xml 19 22 19 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
The half-life of c-myc mRNA in growing and serum-stimulated cells: influence of the coding and 3' untranslated regions and role of ribosome translocation
###end article-title 60
###begin article-title 61
###xml 2 5 2 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
C-myc oncogene expression in estrogen-dependent and -independent breast cancer
###end article-title 61
###begin article-title 62
###xml 13 16 13 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 32 40 32 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Control of c-myc mRNA half-life in vitro by a protein capable of binding to a coding region determinant
###end article-title 62
###begin article-title 63
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Evidence for a 3'-5' decay pathway for c-myc mRNA in mammalian cells
###end article-title 63
###begin article-title 64
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Regulation of c-myc mRNA decay in vitro by a phorbol ester-inducible, ribosome-associated component in differentiating megakaryoblasts
###end article-title 64
###begin article-title 65
Regulation of c-myc mRNA decay by translational pausing in a coding region instability determinant
###end article-title 65
###begin article-title 66
###xml 44 47 44 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 129 136 129 136 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
The 5' and 3' non-coding sequences of the c-myc gene, required in vitro for its post-transcriptional regulation, are dispensable in vivo
###end article-title 66
###begin article-title 67
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
The protein coding region of c-myc mRNA contains a sequence that specifies rapid mRNA turnover and induction by protein synthesis inhibitor
###end article-title 67
###begin article-title 68
###xml 42 45 42 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Coding elements in exons 2 and 3 target c-myc mRNA downregulation during myogenic differentiation
###end article-title 68
###begin article-title 69
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 87 92 <span type="species:ncbi:9606">human</span>
Purification and properties of a protein that binds to the C-terminal coding region of human c-myc mRNA
###end article-title 69
###begin article-title 70
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins
###end article-title 70
###begin article-title 71
A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development
###end article-title 71
###begin article-title 72
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 86 94 86 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
Developmental regulation of CRD-BP, an RNA-binding protein that stabilizes c-myc mRNA in vitro
###end article-title 72
###begin article-title 73
###xml 104 108 <span type="species:ncbi:10090">mice</span>
Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice
###end article-title 73
###begin article-title 74
###xml 47 50 47 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 76 82 76 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CRD-BP</italic>
8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas
###end article-title 74
###begin article-title 75
###xml 45 50 <span type="species:ncbi:9606">human</span>
Overexpression of an mRNA-binding protein in human colorectal cancer
###end article-title 75
###begin article-title 76
Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors
###end article-title 76
###begin article-title 77
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Amplification in human breast cancer of a gene encoding a c-myc mRNA-binding protein
###end article-title 77
###begin article-title 78
###xml 27 42 <span type="species:ncbi:10090">transgenic mice</span>
Mammary tumor induction in transgenic mice expressing an RNA-binding protein
###end article-title 78
###begin article-title 79
Cytoplasmic trafficking of IGF-II mRNA-binding protein by conserved KH domains
###end article-title 79
###begin article-title 80
H19 RNA binds four molecules of insulin-like growth factor II mRNA-binding protein
###end article-title 80
###begin article-title 81
The insulin-like growth factor mRNA binding-protein IMP-1 and the Ras-regulatory protein G3BP associate with tau mRNA and HuD protein in differentiated P19 neuronal cells
###end article-title 81
###begin article-title 82
Characterization of a beta-actin mRNA zipcode-binding protein
###end article-title 82
###begin article-title 83
RNA-binding IMPs promote cell adhesion and invadopodia formation
###end article-title 83
###begin article-title 84
###xml 49 52 46 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signaling
###end article-title 84
###begin article-title 85
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells
###end article-title 85
###begin article-title 86
###xml 16 19 16 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Inhibition of c-myc expression in cells by targeting an RNA-protein interaction using antisense oligonucleotides
###end article-title 86
###begin article-title 87
###xml 136 141 <span type="species:ncbi:9606">human</span>
Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via insulin-like growth factor II-dependent pathway in human K562 leukemia cells
###end article-title 87
###begin article-title 88
Purification and characterization of a novel mammalian endoribonuclease
###end article-title 88
###begin article-title 89
###xml 72 77 <span type="species:ncbi:9606">human</span>
Function and subnuclear distribution of Rpp21, a protein subunit of the human ribonucleoprotein ribonuclease P
###end article-title 89
###begin article-title 90
###xml 87 92 <span type="species:ncbi:9606">human</span>
Autoantigenic properties of some protein subunits of catalytically active complexes of human ribonuclease P
###end article-title 90
###begin article-title 91
###xml 78 83 <span type="species:ncbi:9606">human</span>
Purification and characterization of Rpp25, an RNA-binding protein subunit of human ribonuclease P
###end article-title 91
###begin article-title 92
###xml 42 48 39 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 31 36 <span type="species:ncbi:9606">human</span>
The nucleotide sequence of the human beta-globin gene
###end article-title 92
###begin article-title 93
Hydroxyl radical footprinting: high resolution information about DNA-protein contacts and applications to lambda repressor and Cro protein
###end article-title 93
###begin article-title 94
SMART: A web-based tool for the study of genetically mobile domains
###end article-title 94
###begin article-title 95
###xml 44 49 <span type="species:ncbi:9606">human</span>
Protein-RNA interactions in the subunits of human nuclear RNase P
###end article-title 95
###begin article-title 96
###xml 27 32 <span type="species:ncbi:9606">human</span>
Sequential dimerization of human zipcode-binding protein IMP1 on RNA: a cooperative mechanism providing RNP stability
###end article-title 96
###begin article-title 97
VICKZ proteins: a multi-talented family or regulatory RNA-binding proteins
###end article-title 97
###begin article-title 98
###xml 18 25 <span type="species:ncbi:8355">Xenopus</span>
The KH domains of Xenopus Vg1RBP mediate RNA binding and self-association
###end article-title 98
###begin article-title 99
P-glycoprotein: from genomics to mechanism
###end article-title 99
###begin article-title 100
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 52 55 <span type="species:ncbi:10116">rat</span>
Increased P-glycoprotein messenger RNA stability in rat liver tumors in vivo
###end article-title 100
###begin article-title 101
###xml 18 25 18 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Identification of in vivo P-glycoprotein mRNA decay intermediates in normal liver but not in liver tumors
###end article-title 101
###begin title 102
Figures and Tables
###end title 102
###begin p 103
###xml 36 37 36 37 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 82 83 82 83 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 268 269 267 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
###xml 277 282 <span type="species:ncbi:9606">human</span>
Analysis of purified recombinant His6-tagged proteins by SDS-PAGE. Recombinant His6-tagged mouse CRD-BP was purified using Ni-NTA spin column and dialyzed prior to separation (2 mug) (lane 3) on 12% SDS-PAGE and visualization by Coomasie blue staining. Recombinant His6-tagged human Rpp20 (lane 2), Rpp21 (lane 4), Rpp25 (lane 5) and Rpp40 (lane 7) were also purified and dialyzed in a similar manner before its purity (2 mug) being analyzed on Coomasie blue-stained SDS-PAGE.
###end p 103
###begin p 104
###xml 81 84 81 84 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 321 323 321 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
Electromobility shift assay showing binding of recombinant CRD-BP and Rpp25 to c-myc CRD RNA. About 500 nM of purified recombinant CRD-BP (lane 2) and purified recombinant Rpp20 (lanes 3-5), Rpp21 (lanes 6-8), Rpp25 (lanes 9-11) and Rpp40 (lanes 12-14) (at various concentrations as indicated) were incubated with 40 nM [32P] c-myc CRD RNA nts 1705-1886 (approximately50 000 c.p.m). None (lane 1) indicates no protein was added. The positions of protein-RNA complexes (Bound) and unbound RNA (Unbound) are indicated on the left.
###end p 104
###begin p 105
###xml 48 51 48 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 66 72 63 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 80 83 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 131 132 128 129 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 173 175 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 180 183 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 294 295 291 292 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 330 333 327 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 371 374 368 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 411 414 408 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 456 462 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 503 504 497 498 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 540 543 534 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 585 588 579 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 633 639 624 630 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 674 677 665 668 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
Electromobility shift competition assays with c-myc CRD RNA, beta-globin RNA or MDR-1 RNA. About 350 nM of purified recombinant His6-tagged CRD-BP was incubated with 40 nM [32P] c-myc CRD RNA nts 1705-1886 (50 000 c.p.m) with or without the indicated molar excess of unlabeled competitor RNA. (A) 1-10 molar excess of unlabeled c-myc CRD RNA nts 1705-1886 (lanes 3-6), c-myc CRD RNA nts 1705-1792 (lanes 7-10), MDR-1 RNA nts 746-962 (lanes 11-14) and beta-globin RNA nts 1-145 (lanes 15-18) were used. (B) 10-50 molar excess of unlabeled c-myc CRD RNA nts 1705-1886 (lanes 3 and 4), c-myc CRD RNA nts 1705-1792 (lanes 5 and 6), beta-globin RNA nts 1-145 (lanes 7 and 8) and MDR-1 RNA nts 746-962 (lanes 9 and 10) were used.
###end p 105
###begin p 106
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 51 57 48 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 64 65 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 118 120 115 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 125 128 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 202 203 199 200 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 232 233 229 230 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 256 257 253 254 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 490 491 487 488 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 558 560 555 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 568 574 562 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">globin</italic>
###xml 640 641 634 635 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
CRD-BP-binding affinity for c-myc CRD RNA and beta-globin RNA. (A) An electromobility shift assay showing binding to [32P] c-myc CRD RNA nts 1705-1886 by an increasing amount of purified recombinant His6-tagged CRD-BP (0-1470 nM). (B) Binding activity in (A) was quantified using the PhorphorImager to compare the relative amount of radiolabeled unbound RNA shifted into slower-migrating Complex I and Complex II. Data obtained was then used to plot the saturation binding curve as shown. (C) An electromobility shift assay assessing the ability to bind to [32P] beta-globin RNA nts 1-145 by an increasing amount of purified recombinant His6-tagged CRD-BP (0-3070 nM).
###end p 106
###begin p 107
###xml 28 31 28 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 40 41 40 41 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 94 96 94 96 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 99 102 99 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 172 173 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 202 203 202 203 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 226 227 226 227 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
CRD-BP binding affinity for MDR-1 RNA. (A) An electromobility shift assay showing binding to [32P] MDR-1 RNA nts 746-962 by an increasing amount of purified recombinant His6-tagged CRD-BP (0-4000 nM). (B) Binding activity in (A) was quantified using the PhorphorImager to compare the relative amount of radiolabeled unbound RNA shifted into slower-migrating Complex I and Complex II. Data obtained from three separate experiments was then used to plot the saturation binding curve as shown.
###end p 107
###begin p 108
###xml 21 24 21 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 95 96 95 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 170 172 170 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 177 180 177 180 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 381 382 381 382 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 408 409 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 418 419 418 419 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 490 493 490 493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
CRD-BP shields the c-myc CRD RNA from endonucleolytic attack by a mammalian endoribonuclease. (A) One unit of the purified mammalian endoribonuclease was incubated with [32P] c-myc CRD RNA nts 1705-1886 as described in the Materials and methods section, with (lanes 4, 5, 9, 10, 14, 15) or without (lanes 3, 8 and 13) the presence of 500, 750 or 1500 nM of purified recombinant His6-tagged CRD-BP as shown. (B) As in (A), the purified endoribonuclease was incubated with the radiolabeled c-myc CRD RNA in the absence (lane 2) or presence of 1500 nM of Rpp20 (lane 4), Rpp21 (lane 6) and Rpp40 (lane 8). Lanes 3, 5 and 7 had the purified recombinant proteins only. Numbers on the right indicate the cleavage sites generated by the mammalian endoribonuclease on the CRD RNA substrates.
###end p 108
###begin p 109
###xml 31 34 31 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 104 107 104 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 180 182 180 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 185 188 185 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">MDR</italic>
###xml 379 380 379 380 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 427 430 427 430 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 438 439 438 439 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 492 494 492 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 501 508 498 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-globin</italic>
###xml 627 628 624 625 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
CRD-BP is capable of shielding MDR-1 RNA from endonucleolytic attack by the mammalian endoribonuclease. (A) One unit of the purified mammalian endoribonuclease was incubated with [32P] MDR-1 RNA nts 746-962 as described in the Materials and methods section, without (lane 2) or with the presence of 500 nM (lane 5), 750 nM (lane 4) or 1500 nM (lane 3) of purified recombinant His6-tagged CRD-BP. Lane 2 had the input RNA only. (B) As in (A), the purified endoribonuclease was incubated with [32P] beta-globin RNA nts 1-145 without (lane 3) or with the presence of 750 nM (lane 4) or 1500 nM (lane 5) of purified recombinant His6-tagged CRD-BP. Lane 1 had the input RNA only.
###end p 109
###begin p 110
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 104 107 104 107 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(A)</bold>
###xml 115 117 115 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 301 302 301 302 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 591 594 591 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 847 850 847 850 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(B)</bold>
###xml 901 904 901 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">myc</italic>
###xml 1039 1040 1039 1040 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 1181 1183 1181 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 1261 1263 1261 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
Mapping of CRD-BP-binding sites on c-myc CRD RNA using the hydroxyl radical-mediated cleavage reaction. (A) 45 nM [32P] c-myc CRD RNA nts 1705-1886 was subjected to Fe(II)/EDTA cleavage reaction in EMSA-binding buffer in the absence (lane 3) or presence (lanes 4-7) of 1500 nM purified recombinant His6-tagged CRD-BP. Reaction samples were run on a 8% denaturing polyacrylamide gel, fixed, dried and subjected to autoradiography as described in the Materials and methods section. Lane 8 is the input RNA. Lanes 1 and 2 represent RNase T1 digest and alkaline hydrolysis of the radiolabeled c-myc CRD RNA respectively. Regions highlighted by rectangles showed significant reductions in cleavage. Numbers on the left indicate guanosine cleavage sites of RNase T1 digest and numbers on the right indicate the hydroxyl radical-mediated cleavage sites. (B) Identified CRD-BP-binding sites on sequences of c-myc CRD RNA nts 1705-1886. Underlined sequences indicate the CRD-BP-binding sites as determined by the hydroxyl radical foot-printing in (A). Bolded sequences indicate the putative CRD-BP-binding sites as previously determined using antisense oligonucleotides competition method (29). Arrows indicate cleavage sites generated by the purified endoribonuclease (31).
###end p 110

